Apixaban

Results: 107



#Item
81Chronic Disease and Medical Innovation in an Aging Nation  The Silver Book: Atrial Fibrillation (AFib) ®  Skyrocketing Prevalence

Chronic Disease and Medical Innovation in an Aging Nation The Silver Book: Atrial Fibrillation (AFib) ® Skyrocketing Prevalence

Add to Reading List

Source URL: www.silverbook.org

Language: English - Date: 2013-02-20 18:48:20
82New Oral Anticoagulants Dabigatran Rivaroxaban Pradaxa® Xarelto®  Apixaban

New Oral Anticoagulants Dabigatran Rivaroxaban Pradaxa® Xarelto® Apixaban

Add to Reading List

Source URL: professionalsblog.clotconnect.org

- Date: 2014-04-07 09:30:38
    83-------------------------------CONTRAINDICATIONS----------------------------- Active pathological bleeding (4)  Severe hypersensitivity to ELIQUIS (4) HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not i

    -------------------------------CONTRAINDICATIONS----------------------------- Active pathological bleeding (4)  Severe hypersensitivity to ELIQUIS (4) HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not i

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    Language: English - Date: 2014-01-31 12:06:00
    84About PharmaCare   B.C. PharmaCare is a government‐funded drug plan. It helps British Columbians with  the cost of eligible prescription drugs and specific medical supplies.    Details of Dru

    About PharmaCare  B.C. PharmaCare is a government‐funded drug plan. It helps British Columbians with  the cost of eligible prescription drugs and specific medical supplies.   Details of Dru

    Add to Reading List

    Source URL: www.health.gov.bc.ca

    Language: English - Date: 2014-03-05 12:02:51
    85About PharmaCare   B.C. PharmaCare is a government‐funded drug plan. It helps British Columbians with  the cost of eligible prescription drugs and specific medical supplies.    Details of Dru

    About PharmaCare  B.C. PharmaCare is a government‐funded drug plan. It helps British Columbians with  the cost of eligible prescription drugs and specific medical supplies.   Details of Dru

    Add to Reading List

    Source URL: www.health.gov.bc.ca

    Language: English - Date: 2014-06-20 13:28:33
    86hrs_hr2012_sp13_flyer_cover_v2

    hrs_hr2012_sp13_flyer_cover_v2

    Add to Reading List

    Source URL: www.hrsonline.org

    Language: English
    87Provincial Drug Programs P. O. Box 2000 Charlottetown PE C1A 7N8[removed]Toll Free on PEI)  Programmes provinciaux de médicaments

    Provincial Drug Programs P. O. Box 2000 Charlottetown PE C1A 7N8[removed]Toll Free on PEI) Programmes provinciaux de médicaments

    Add to Reading List

    Source URL: www.gov.pe.ca

    Language: English - Date: 2014-06-04 09:21:06
    88SPECIAL AUTHORIZATION REQUEST FORM The Newfoundland and Labrador Prescription Drug Program (NLPDP) Request for Coverage of Thromboembolism Prevention Following Hip or Knee Replacement Surgery Pharmaceutical Services Depa

    SPECIAL AUTHORIZATION REQUEST FORM The Newfoundland and Labrador Prescription Drug Program (NLPDP) Request for Coverage of Thromboembolism Prevention Following Hip or Knee Replacement Surgery Pharmaceutical Services Depa

    Add to Reading List

    Source URL: www.health.gov.nl.ca

    Language: English - Date: 2013-03-19 12:37:07
    89Provincial Drug Programs P. O. Box 2000 Charlottetown PE C1A 7N8[removed]Toll Free on PEI)  Programmes provinciaux de médicaments

    Provincial Drug Programs P. O. Box 2000 Charlottetown PE C1A 7N8[removed]Toll Free on PEI) Programmes provinciaux de médicaments

    Add to Reading List

    Source URL: www.gov.pe.ca

    Language: English - Date: 2014-02-04 07:05:49
    90WATCHMAN™ Left Atrial Appendage Closure (LAAC) Therapy for Patients with Non-Valvular Atrial Fibrillation Sponsor’s Executive Summary P130013 Circulatory System Devices Panel Meeting

    WATCHMAN™ Left Atrial Appendage Closure (LAAC) Therapy for Patients with Non-Valvular Atrial Fibrillation Sponsor’s Executive Summary P130013 Circulatory System Devices Panel Meeting

    Add to Reading List

    Source URL: www.fda.gov

    Language: English